Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 119705
Published online Sep 19, 2026. doi: 10.5498/wjp.119705
Published online Sep 19, 2026. doi: 10.5498/wjp.119705
Table 1 Comparison of baseline data between the two groups, mean ± SD/n (%)
| Baseline data | Group A (n = 126) | Group B (n = 126) | t/χ2 value | P value |
| Male/female | 67/59 | 65/61 | 0.064 | 0.801 |
| Age (years) | 71.14 ± 5.36 | 70.48 ± 5.89 | 0.930 | 0.353 |
| Clinical stage | 0.398 | 0.528 | ||
| Stage III | 57 (45.24) | 62 (49.20) | ||
| Stage IV | 69 (54.76) | 64 (50.79) | ||
| Cancer type | 0.886 | 0.971 | ||
| Lung cancer | 32 (25.40) | 29 (23.02) | ||
| Gastric cancer | 26 (20.63) | 30 (23.81) | ||
| Liver cancer | 23 (18.25) | 21 (16.67) | ||
| Colorectal cancer | 31 (24.60) | 34 (26.98) | ||
| Breast cancer | 10 (7.94) | 8 (6.35) | ||
| Esophageal cancer | 4 (3.17) | 4 (3.17) | ||
| Living situation | 0.941 | 0.816 | ||
| Living alone | 10 (7.94) | 8 (6.35) | ||
| Living with spouse only | 51 (40.48) | 58 (46.03) | ||
| Living with spouse and children | 53 (42.06) | 50 (39.68) | ||
| Other | 12 (9.52) | 10 (7.94) | ||
| Education level | 0.862 | 0.835 | ||
| Illiterate | 12 (9.52) | 15 (11.90) | ||
| Primary school | 44 (34.92) | 43 (34.13) | ||
| Junior high school | 36 (28.57) | 39 (30.95) | ||
| High school or above | 34 (26.98) | 29 (23.02) | ||
| Comorbidities | ||||
| Hyperlipidemia | 57 (45.24) | 52 (41.27) | 0.404 | 0.525 |
| Hypertension | 46 (36.51) | 53 (42.06) | 0.815 | 0.367 |
| Type 2 diabetes | 31 (24.60) | 36 (28.57) | 0.508 | 0.476 |
| Coronary heart disease | 19 (15.08) | 22 (17.46) | 0.262 | 0.609 |
Table 2 Comparison of Hamilton Anxiety scale and Hamilton Depression scale scores between the two groups, mean ± SD
Table 3 Comparison of Revised Piper Fatigue Scale scores between the two groups, mean ± SD
| Group | n | Cognition | Sense | Emotion | Behavior | ||||
| Before intervention | After intervention | Before intervention | After intervention | Before intervention | After intervention | Before intervention | After intervention | ||
| Group A | 126 | 6.36 ± 0.74 | 5.14 ± 0.52a | 5.93 ± 0.78 | 4.86 ± 0.64a | 6.47 ± 0.69 | 5.42 ± 0.59a | 5.67 ± 0.65 | 4.02 ± 0.42a |
| Group B | 126 | 6.29 ± 0.81 | 4.55 ± 0.68a | 6.02 ± 0.74 | 4.47 ± 0.60a | 6.52 ± 0.71 | 4.60 ± 0.61a | 5.59 ± 0.71 | 3.54 ± 0.50a |
| t value | 0.716 | 7.737 | -0.940 | 4.990 | -0.567 | 10.846 | 0.933 | 8.251 | |
| P value | 0.475 | 0.000 | 0.348 | 0.000 | 0.571 | 0.000 | 0.352 | 0.000 | |
Table 4 Comparison of Edmonton Symptom Assessment System scores between the two groups, mean ± SD
| Dimension | Time | Group A (n = 126) | Group B (n = 126) | t value | P value |
| Drowsiness | Before intervention | 5.92 ± 0.74 | 6.01 ± 0.74 | -0.965 | 0.335 |
| After intervention | 3.45 ± 0.50a | 3.07 ± 0.38a | 6.792 | 0.000 | |
| Weakness | Before intervention | 5.98 ± 0.78 | 5.87 ± 0.82 | 1.091 | 0.276 |
| After intervention | 4.56 ± 0.64a | 3.98 ± 0.27a | 9.373 | 0.000 | |
| Nausea | Before intervention | 4.54 ± 0.63 | 4.46 ± 0.67 | 0.976 | 0.330 |
| After intervention | 2.91 ± 0.77a | 2.44 ± 0.61a | 5.371 | 0.000 | |
| Pain | Before intervention | 6.15 ± 0.77 | 6.05 ± 0.70 | 1.079 | 0.282 |
| After intervention | 4.41 ± 0.62a | 3.95 ± 0.40a | 6.998 | 0.000 | |
| Shortness of breath | Before intervention | 3.57 ± 0.63 | 3.59 ± 0.60 | -0.258 | 0.797 |
| After intervention | 2.02 ± 0.31a | 1.62 ± 0.49a | 7.744 | 0.000 | |
| Anxiety | Before intervention | 6.40 ± 0.92 | 6.33 ± 0.86 | 0.624 | 0.533 |
| After intervention | 3.43 ± 0.60a | 2.42 ± 0.50a | 14.516 | 0.000 | |
| Depression | Before intervention | 6.37 ± 0.94 | 6.44 ± 0.98 | -0.579 | 0.563 |
| After intervention | 3.59 ± 0.62a | 2.92 ± 0.40a | 10.193 | 0.000 | |
| Insomnia | Before intervention | 6.48 ± 0.92 | 6.56 ± 0.93 | -0.686 | 0.493 |
| After intervention | 4.54 ± 0.62a | 4.00 ± 0.36a | 8.455 | 0.000 | |
| Poor appetite | Before intervention | 5.93 ± 0.65 | 5.99 ± 0.75 | -0.679 | 0.498 |
| After intervention | 4.52 ± 0.60a | 4.03 ± 0.40a | 7.627 | 0.000 | |
| Impaired overall well-being | Before intervention | 5.54 ± 0.63 | 5.50 ± 0.58 | 0.524 | 0.601 |
| After intervention | 4.49 ± 0.50a | 3.96 ± 0.41a | 9.201 | 0.000 |
Table 5 Comparison of Pittsburgh Sleep Quality Index scale scores between the two groups, mean ± SD
| Dimension | Time | Group A (n = 126) | Group B (n = 126) | t value | P value |
| Sleep quality | Before intervention | 2.42 ± 0.50 | 2.54 ± 0.50 | -1.905 | 0.058 |
| After intervention | 1.51 ± 0.62a | 1.00 ± 0.47a | 7.358 | 0.000 | |
| Sleep latency | Before intervention | 2.01 ± 0.37 | 1.99 ± 0.37 | 0.429 | 0.668 |
| After intervention | 1.05 ± 0.42a | 0.57 ± 0.50a | 8.251 | 0.000 | |
| Sleep duration | Before intervention | 2.49 ± 0.50 | 2.48 ± 0.50 | 0.159 | 0.874 |
| After intervention | 1.42 ± 0.61a | 1.06 ± 0.34a | 5.786 | 0.000 | |
| Sleep efficiency | Before intervention | 2.46 ± 0.50 | 2.52 ± 0.50 | -0.952 | 0.342 |
| After intervention | 1.95 ± 0.40a | 1.53 ± 0.64a | 7.734 | 0.000 | |
| Sleep disorders | Before intervention | 2.42 ± 0.50 | 2.54 ± 0.50 | -1.905 | 0.058 |
| After intervention | 2.02 ± 0.46a | 1.60 ± 0.59a | 6.302 | 0.000 | |
| Hypnotic drugs | Before intervention | 2.02 ± 0.39 | 1.98 ± 0.35 | 0.857 | 0.392 |
| After intervention | 1.50 ± 0.50 | 1.02 ± 0.44 | 8.090 | 0.000 | |
| Daytime function | Before intervention | 2.51 ± 0.50 | 2.53 ± 0.50 | -0.317 | 0.751 |
| After intervention | 1.97 ± 0.38a | 1.51 ± 0.50a | 8.222 | 0.000 |
Table 6 Comparison of Functional Assessment of Cancer Therapy-General scores between the two groups, mean ± SD
| Group | n | Physical | Social/family | Emotion | Function | ||||
| Before intervention | After intervention | Before intervention | After intervention | Before intervention | After intervention | Before intervention | After intervention | ||
| Group A | 126 | 11.02 ± 1.44 | 9.98 ± 1.13a | 9.56 ± 0.98 | 9.43 ± 0.93 | 7.52 ± 0.93 | 9.99 ± 1.08a | 6.52 ± 0.63 | 8.06 ± 0.76a |
| Group B | 126 | 11.25 ± 1.41 | 10.43 ± 0.92a | 9.46 ± 0.88 | 13.74 ± 1.28a | 7.43 ± 0.95 | 13.59 ± 1.40a | 6.59 ± 0.54 | 9.04 ± 0.75a |
| t value | -1.281 | -3.467 | 0.852 | -30.578 | 0.760 | -22.854 | -0.947 | -10.302 | |
| P value | 0.201 | 0.001 | 0.395 | 0.000 | 0.448 | 0.000 | 0.345 | 0.000 | |
Table 7 Results of multiple linear regression analysis on factors influencing the improvement of mental disorder burden (n = 126)
| Independent variables | Model 1 Δ HAMA | Model 2 Δ HAMD | Model 3 Δ PSQI | |||
| β (95%CI) | P value | β (95%CI) | P value | β (95%CI) | P value | |
| Age | -0.105 (-0.420 to 0.210) | 0.483 | -0.084 (-0.389 to 0.221) | 0.601 | -0.053 (-0.283 to 0.177) | 0.661 |
| Sex | 0.085 (-0.224 to 0.394) | 0.562 | 0.117 (-0.185 to 0.419) | 0.441 | 0.041 (-0.187 to 0.269) | 0.718 |
| Clinical stage | -0.151 (-0.464 to 0.162) | 0.339 | -0.250 (-0.564 to | 0.041 | -0.125 (-0.357 to 0.107) | 0.262 |
| Living status | -0.179 (-0.492 to 0.134) | 0.253 | -0.310 (-0.618 to | 0.021 | -0.142 (-0.374 to 0.090) | 0.230 |
| Education level | 0.187 (-0.121 to 0.495) | 0.226 | 0.351 (0.040 to 0.662) | 0.027 | 0.147 (-0.082 to 0.376) | 0.203 |
| Pre-intervention ESAS pain score | -0.283 (-0.594 to | 0.028 | -0.162 (-0.473 to 0.149) | 0.311 | -0.331 (-0.562 to | 0.005 |
| Pre-intervention FACT-G social/family well-being score | 0.316 (0.006 to 0.626) | 0.045 | 0.267 (-0.043 to 0.577) | 0.087 | 0.176 (-0.051 to 0.403) | 0.124 |
| Pre-intervention total PFS-R score | -0.214 (-0.525 to 0.097) | 0.185 | -0.223 (-0.534 to 0.088) | 0.157 | -0.287 (-0.518 to | 0.014 |
| Caregiver training completion | 0.374 (0.062 to 0.686) | 0.020 | 0.232 (-0.084 to 0.548) | 0.142 | 0.201 (-0.033 to 0.435) | 0.092 |
| Pain control target reached | 0.243 (-0.071 to 0.557) | 0.128 | 0.203 (-0.113 to 0.519) | 0.206 | 0.408 (0.176 to 0.640) | 0.001 |
| Model statistics | R2 = 0.361, after adjustment R2 = 0.294 | R2 = 0.332, after adjustment R2 = 0.264 | R2 = 0.398, after adjustment R2 = 0.332 | |||
| F = 5.115, P < 0.001 | F = 4.475, P < 0.001 | F = 6.013, P < 0.001 | ||||
- Citation: Hou R, Xue XR, Qiao JY, Liu BX. Home-based hospice care alleviates the burden of mental disorders in older patients with advanced cancer. World J Psychiatry 2026; 16(9): 119705
- URL: https://www.wjgnet.com/2220-3206/full/v16/i9/119705.htm
- DOI: https://dx.doi.org/10.5498/wjp.119705